-+ 0.00%
-+ 0.00%
-+ 0.00%

IMVIONIX ACQUIRES U.S. AND CANADIAN RIGHTS TO BEOVU® (BROLUCIZUMAB-DBLL), MARKING THE COMPANY'S OFFICIAL LAUNCH

Reuters·11/10/2026 14:32:20